Keith Myers, PA
Physician Assistant · Elk Grove, CANPI 1770622862
Payments from drug & device makers
Across 16 payments — averaging $32.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$128
- Otsuka America Pharmaceutical, Inc.$87
- Axonics, Inc.$87
- 180 Medical, Inc.$53
- Boston Scientific$40
- Progenics Pharmaceuticals, Inc.$29
- plus $96 from 5 others
What the payments were for
- Food & beverage$520100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $128 |
| Otsuka America Pharmaceutical, Inc. | 1 | $87 |
| Axonics, Inc. | 1 | $87 |
| 180 Medical, Inc. | 2 | $53 |
| Boston Scientific | 1 | $40 |
| Progenics Pharmaceuticals, Inc. | 1 | $29 |
| Johnson & Johnson | 2 | $25 |
| Hologic Sales And Service, LLC | 1 | $25 |
| AbbVie | 1 | $19 |
| Novo Nordisk | 1 | $16 |
| SRS Medical Systems, Inc. | 1 | $11 |
How this compares
$520 in reported general payments places this provider in the 60th percentile of 10,423 physician assistant providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 31 | $16,291 |
| MyrbetriqMirabegron | 21 | $12,604 |
| Tamsulosin Hcl | 275 | $4,745 |
| Estradiol | 18 | $1,102 |
| Testosterone Cypionate | 31 | $1,066 |
| Finasteride | 76 | $880 |
| Cefpodoxime Proxetil | 17 | $779 |
| Solifenacin Succinate | 19 | $673 |
| Ketoconazole | 12 | $670 |
| Doxazosin Mesylate | 46 | $633 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 35 | $620 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $536 |
| Trospium Chloride | 18 | $497 |
| Oxybutynin Chloride ErOxybutynin Chloride | 28 | $484 |
| Gabapentin | 29 | $464 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Elk Grove
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.